Chanca piedra (Phyllanthus niruri, gale of the wind) and hepatitis B
What 2 graded rows on chanca piedra (phyllanthus niruri, gale of the wind) agree on for hepatitis B, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Chanca piedra (Phyllanthus niruri, gale of the wind) page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Chanca piedra (Phyllanthus niruri, gale of the wind) page, with its PubMed record.
Your question
Chanca piedra (Phyllanthus niruri, gale of the wind) and hepatitis B
2 rows · 1,373 peopleSplit. 1 row found no difference and 1 had mixed results.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 17
- People
- 1,373
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade C, is a meta-analysis of 1,326 people (2011) and reported mixed results.
The rows run from 47 to 1,326 people, published from 2011 to 2018: 1 pooled review and 1 single study.
The rows
1 no difference · 1 mixed- DGrade DHepatitis B viral load · No difference
RCT · n 47 · 2018 · Adults with chronic hepatitis B
Not stated in the abstract · 12 months
No difference in viral load versus placebo and no HBsAg clearance; kidney function was unchanged and no serious adverse events occurred. The trial was stopped early for lack of benefit.
Row on the Chanca piedra (Phyllanthus niruri, gale of the wind) page · PubMed 30372693 (opens PubMed)
- CGrade CHepatitis B virus markers · Mixed
Meta-analysis, 16 studies · n 1,326 · 2011 · People with chronic hepatitis B in randomized trials (mostly China)
Varied by trial · Varied by trial
Versus placebo (one trial, 42 people) there was no difference in HBeAg seroconversion. Added to antivirals, Phyllanthus improved HBV DNA and HBeAg measures, but with substantial heterogeneity and risk of bias; no serious adverse events were reported.
Row on the Chanca piedra (Phyllanthus niruri, gale of the wind) page · PubMed 21491412 (opens PubMed)